• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Semler Scientific Inc. (Amendment)

    2/12/24 12:31:49 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SMLR alert in real time by email
    SC 13G/A 1 d775482dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)

     

     

    Semler Scientific, Inc.

    (Name of Issuer)

    Common Stock, $0.001 par value

    (Title of Class of Securities)

    81684M104

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 81684M104

     

     1   

    Names of reporting persons

     

    Topline Capital Management, LLC

     2   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☐

     

     3   

    SEC use only

     

     4   

    Citizenship or place of organization

     

    California

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

        5   

    Sole voting power

     

    0

        6   

    Shared voting power

     

    0

        7   

    Sole dispositive power

     

    0

        8   

    Shared dispositive power

     

    0

     9   

    Aggregate amount beneficially owned by each reporting person

     

    0

    10   

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    11   

    Percent of class represented by amount in Row (9)

     

    0%

    12   

    Type of reporting person (see instructions)

     

    IA

     

    2


    CUSIP No. 81684M104

     

     1   

    Names of reporting persons

     

    Collin McBirney

     2   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☐

     

     3   

    SEC use only

     

     4   

    Citizenship or place of organization

     

    USA

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

        5   

    Sole voting power

     

    0

        6   

    Shared voting power

     

    0

        7   

    Sole dispositive power

     

    0

        8   

    Shared dispositive power

     

    0

     9   

    Aggregate amount beneficially owned by each reporting person

     

    0

    10   

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    11   

    Percent of class represented by amount in Row (9)

     

    0%

    12   

    Type of reporting person (see instructions)

     

    IN/HC

     

    3


    CUSIP No. 81684M104

     

     1   

    Names of reporting persons

     

    Topline Capital Partners, LP

     2   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☐

     

     3   

    SEC use only

     

     4   

    Citizenship or place of organization

     

    Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

        5   

    Sole voting power

     

    0

        6   

    Shared voting power

     

    0

        7   

    Sole dispositive power

     

    0

        8   

    Shared dispositive power

     

    0

     9   

    Aggregate amount beneficially owned by each reporting person

     

    0

    10   

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    11   

    Percent of class represented by amount in Row (9)

     

    0%

    12   

    Type of reporting person (see instructions)

     

    PN

     

    4


    Item 1

     

      (a)

    Name of Issuer:

    Semler Scientific, Inc.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA 95051

    Item 2

     

      (a)

    Name of Persons Filing:

    Topline Capital Management, LLC (“TCM”)

    Collin McBirney

    Topline Capital Partners, LP (“TCP” or the “Fund”)

     

      (b)

    Address of Principal Business Office or, if none, Residence:

    544 Euclid Street, Santa Monica, CA 90402

     

      (c)

    Citizenship:

    Reference is made to Row 4 of pages 2 - 4 of this Schedule 13G (this “Schedule”), which are incorporated by reference herein.

     

      (d)

    Title of Class of Securities:

    Common Stock, $0.001 par value

     

      (e)

    CUSIP Number: 81684M104

    Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

    Not applicable.

    Item 4. Ownership 

    Reference is hereby made to Rows 5-9 and 11 of pages 2, 3 and 4 of this Schedule, which are incorporated by reference herein.

    As of December 31, 2023, the Fund does not beneficially own shares of the issuer’s common stock.

     

    5


    Item 5. Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☑

    Item 6. Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or    Control Person

    Not applicable.

    Item 8. Identification and Classification of Members of the Group

    Not applicable.

    Item 9. Notice of Dissolution of Group

    Not applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    6


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: February 12, 2024

     

    TOPLINE CAPITAL MANAGEMENT, LLC

    By:   /s/ Collin McBirney
     

    Collin McBirney

     

    Managing Member

    TOPLINE CAPITAL PARTNERS, LP

    By: Topline Capital Management, LLC,
    its general partner

    By:   /s/ Collin McBirney
     

    Collin McBirney

     

    Managing Member

    COLLIN MCBIRNEY

    /s/ Collin McBirney

     

    7


    EXHIBIT LIST

     

    Exhibit A    Joint Filing Undertaking
    Get the next $SMLR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SMLR

    DatePrice TargetRatingAnalyst
    7/28/2025Overweight
    Cantor Fitzgerald
    7/8/2025$101.00Buy
    The Benchmark Company
    11/2/2022$60.00 → $45.00Buy → Neutral
    B. Riley Securities
    3/7/2022$145.00 → $70.00Buy
    B. Riley Securities
    11/2/2021$175.00 → $145.00Buy
    B. Riley Securities
    10/26/2021$151.00 → $175.00Buy
    B. Riley Securities
    More analyst ratings

    $SMLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Murphy-Chutorian Douglas exercised 60,000 shares at a strike of $2.56, sold $873,566 worth of shares (28,604 units at $30.54), gifted 31,396 shares and received a gift of 31,396 shares (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    8/26/25 4:05:20 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Director Brunell Natalie

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    6/26/25 4:15:11 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Semler Eric exercised 6,750 shares at a strike of $23.32, increasing direct ownership by 1% to 636,346 units (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    6/12/25 6:01:48 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    SEC Filings

    View All

    Semler Scientific Inc. filed SEC Form 8-K: Leadership Update

    8-K - Semler Scientific, Inc. (0001554859) (Filer)

    10/17/25 4:10:11 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events

    8-K - Semler Scientific, Inc. (0001554859) (Filer)

    10/3/25 4:18:26 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 425 filed by Semler Scientific Inc.

    425 - Semler Scientific, Inc. (0001554859) (Subject)

    10/2/25 4:35:26 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Semler Scientific

    Cantor Fitzgerald initiated coverage of Semler Scientific with a rating of Overweight

    7/28/25 9:00:02 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    The Benchmark Company initiated coverage on Semler Scientific with a new price target

    The Benchmark Company initiated coverage of Semler Scientific with a rating of Buy and set a new price target of $101.00

    7/8/25 8:33:26 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Semler Scientific from Buy to Neutral and set a new price target of $45.00 from $60.00 previously

    11/2/22 6:23:13 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Semler Eric was granted 1,318 shares and bought $1,896,500 worth of shares (50,000 units at $37.93), increasing direct ownership by 9% to 621,721 units (SEC Form 4)

    4 - Semler Scientific, Inc. (0001554859) (Issuer)

    11/12/24 6:05:40 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction

    DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") entered into a definitive agreement to acquire Semler Scientific, Inc. ("Semler Scientific") in an all-stock transaction. In addition, Strive announced the purchase of 5,816 Bitcoin to its corporate treasury at an average price of $116,047 per Bitcoin, for a total purchase price of $675,000,000, inclusive of fees and expenses, bringing Strive's total Bitcoin holdings to 5,886. Transaction details: Deal represents an approximately 210% premium, equivalent to approximately $90.52 per share, based on the trading price of Semler Scientific common stock and Strive Class A common stock as of the market clos

    9/22/25 8:15:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025

    CAMPBELL, Calif., Aug. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, today reported financial results for the second quarter ended June 30, 2025 and provided an update on its Bitcoin holdings and other key performance indicators (KPIs). "We have made excellent progress with our Bitcoin treasury strategy," said Eric Semler, executive chairman of Semler Scientific. "We purchased approximately $195.4 million of Bitcoin s

    8/4/25 4:01:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results

    CAMPBELL, Calif., July 21, 2025 /PRNewswire/ --Semler Scientific, Inc. (NASDAQ:SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced it will report financial results for the second quarter ended June 30, 2025, after the close of U.S. financial markets on Monday, August 4, 2025. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a live video webinar at 4:30 pm ET the same day. Eric Semler, executive chairman, Renae Cormier, chief financial officer, and Joe Burnett, director of Bitcoin strategy, will join him on the call. Please submi

    7/21/25 5:48:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Leadership Updates

    Live Leadership Updates

    View All

    Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction

    DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") entered into a definitive agreement to acquire Semler Scientific, Inc. ("Semler Scientific") in an all-stock transaction. In addition, Strive announced the purchase of 5,816 Bitcoin to its corporate treasury at an average price of $116,047 per Bitcoin, for a total purchase price of $675,000,000, inclusive of fees and expenses, bringing Strive's total Bitcoin holdings to 5,886. Transaction details: Deal represents an approximately 210% premium, equivalent to approximately $90.52 per share, based on the trading price of Semler Scientific common stock and Strive Class A common stock as of the market clos

    9/22/25 8:15:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027

    CAMPBELL, Calif., June 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Joe Burnett as director of Bitcoin strategy. Semler Scientific also announced that it plans to hold 10,000 Bitcoins by year-end 2025, 42,000 by year-end 2026 and 105,000 by year-end 2027, using proceeds from equity and debt financings and cash flows from operations.  "We are excited to have Joe join our Bitcoin strategy

    6/19/25 4:45:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Appoints Natalie Brunell to its Board of Directors

    CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its leadership within the Bitcoin community. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Sci

    5/19/25 8:00:00 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Financials

    Live finance-specific insights

    View All

    Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025

    CAMPBELL, Calif., Aug. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, today reported financial results for the second quarter ended June 30, 2025 and provided an update on its Bitcoin holdings and other key performance indicators (KPIs). "We have made excellent progress with our Bitcoin treasury strategy," said Eric Semler, executive chairman of Semler Scientific. "We purchased approximately $195.4 million of Bitcoin s

    8/4/25 4:01:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC

    CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a

    5/13/25 4:01:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 165 BTC; Now Holds 3,467 BTC; YTD BTC Yield of 23.8%; Earnings Release Date and Conference Call for First Quarter 2025 Financial Results

    SANTA CLARA, Calif., April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference call. BTC Update Between April 25, 2025 and April 29, 2025, Semler Scientific acquired 165 bitcoins for $15.7 million with an average purchase price of $94,931 pe

    4/30/25 8:00:00 AM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SMLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Semler Scientific Inc.

    SC 13G - Semler Scientific, Inc. (0001554859) (Subject)

    11/26/24 12:09:40 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    11/12/24 4:15:46 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care